Urodynamic Devices Market

Urodynamic Devices Market Stydy by Uroflowmetry, Ambulatory Urodynamic Devices, Cystometers, Video Urodynamic Devices, Electromyography, and others from 2023 to 2033

Analysis of Urodynamic Devices Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Urodynamic Devices Market Outlook (2023 to 2033)

The global urodynamic devices market is valued at US$ 299.5 million in 2023 and is extrapolated to reach a valuation of US$ 581.5 million by the end of 2033. Worldwide shipments of urodynamic devices are anticipated to increase at 6.8% CAGR over the next ten years.

Increasing investments in healthcare infrastructure development and the high prevalence of chronic kidney disease are the prime prospects that are anticipated to augment shipments of urodynamic devices over the next ten years. The growing availability of urology devices and other urine test devices is also expected prominently influence urodynamic device sales throughout the forecast period.

High incidence of bladder cancer, increasing rate of hospitalization, growing geriatric population, rising awareness regarding lower urinary tract infections, increasing healthcare expenditure, supportive government initiatives, and technological advancements in medical diagnostic equipment are other prospects that could potentially uplift urodynamic devices market development in the future. However, the high costs of urodynamic equipment and stringent regulatory mandates are predicted to hinder urodynamic system sales over the coming years.

Initiatives to promote awareness about renal disorders and the establishment of new non-profit organizations to help people suffering from these disorders are expected to create new opportunities for urodynamic device suppliers through 2033.

The APAC region is anticipated to emerge as the most opportune regional market in the global landscape across the forecast period owing to the growing incidence of kidney disorders and rising investments in healthcare infrastructure development. China and India are estimated to be the key markets in this region owing to increasing awareness regarding chronic kidney disease and bladder cancer.

A detailed breakdown of supply chain management, product standards, local supply, global demand, and other prime trends influencing market growth has been listed in this recently revised urodynamic devices market research study by Fact.MR, a market research and competitive intelligence provider.

Report Attributes


Urodynamic Devices Market Size (2023)

US$ 299.5 Million

Projected Market Value (2033F)

US$ 581.8 Million

Global Market Growth Rate (2023 to 2033)

6.8% CAGR

Leading Regional Market


Key Companies Profiled

  • Best Medical International Inc.
  • CooperSurgical
  • Santron Meditronic
  • Neomedix Systems Pty. Ltd.
  • Laborie Medical Technologies
  • Cook Medical
  • Albyn Medical Ltd.
  • Ambu Inc.
  • Medica SpA
  • Dantec Dynamics A/S
  • Boston Scientific Corporation
  • Digitimer Ltd.
  • CooperSurgical Inc.
  • Verathon Inc.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Factors are Influencing Shipments of Urodynamic Devices?

“High Prevalence of Lower Urinary Tract Infections & Chronic Kidney Disorder”

The world has been witnessing a steady rise in the incidence of chronic kidney disorder in recent years and this trend is projected to boost sales of urodynamic devices over the coming years. Increasing awareness regarding lower urinary tract infections, bladder cancer, and CKD is another key aspect that is anticipated to bolster market development in the future.

Supportive government initiatives and increasing spending on healthcare are other prospects that are anticipated to result in high demand for CKD treatments and urodynamic equipment through 2033.

  • As per the World Kidney Day campaign, around one in ten adults are suffering from chronic kidney disease and this is projected to become the fifth most common reason for loss of life by the end of 2040.

“Stringent Regulatory Mandates and High Costs of Medical Equipment”

Urodynamic equipment is usually expensive in nature and this is anticipated to be a prime constraint for market development in the future. The aforementioned factor is expected to limit the uptake of urodynamic systems in developing economies where institutions have tight budgetary constraints. Moreover, the changing regulatory landscape and implementation of strict regulations are also expected to restrain sales of urodynamic devices across the forecast period.

Urodynamic devices market summary and forecast by Fact.MR

What Strategies are Start-ups Opting for to Penetrate This Industry?

“New Companies Launching Innovative Products and Raising Capital to Advance Business Potential”

Upcoming urodynamic device manufacturers are focusing on the development and launch of new and innovative products that help them maximize their sales potential in the global landscape.

  • In July 2022, Gemini Medical Technologies, a company focused on providing quality medical devices announced the launch of new urodynamic equipment. The newly launched devices are developed by MEDKONSULT Medical Technology.

Urodynamic device companies are also focusing on raising new capital to advance their business potential and compete with established market players.

  • In June 2022, Bright Uro Inc., a medical technology company based in the United States emerged from stealth mode with a seed financing of US$ 4 million from Fred Moll and other investors. The company has also revealed that it had secured an additional US$ 2 million from the National Institute of Health (NIH) through a phase II small business innovation research (SBIR) grant.

A comprehensive analysis of how start-ups are impacting the pricing trends through their new developments has been discussed in detail in this latest Fact.MR urodynamic devices market research survey.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Country-wise Insights

How Will Urodynamic Device Sales Fare in Japan?

“High Senescent Population to Drive Urodynamic Equipment Demand”

Japan’s aging population has been at the helm of the healthcare industry in the country for quite a while now and this trend is projected to be a prime driver for urodynamic device demand as well. People over the age of 60 are prone to contracting urinary tract and renal disorders and this is anticipated to primarily promulgate sales of urodynamic devices in Japan over the next ten years.

Increasing investments in healthcare infrastructure development, the launch of supportive initiatives for people suffering from kidney diseases, and the growing availability of novel urodynamic equipment are other aspects that govern market evolution in Japan across the forecast period.

Are European Countries Opportune Markets for Urodynamic Device Suppliers?

“Increasing Hospitalization Due to High Prevalence of Kidney Infections”

Several people are being admitted to hospitals due to the increasing incidence of kidney infections and urinary tract infections. This rising rate of hospitalization is anticipated to create a lucrative demand for urodynamic devices in European countries such as the United Kingdom, Germany, France, and Italy across the forecast period.

  • As per statistics provided by Kidney Care UK, around 3.5 million people in the country are suffering from chronic kidney disease (CKD) and around 20 people develop kidney failure in the United Kingdom daily.

Supportive government initiatives and increasing healthcare expenditure are other aspects that could potentially create an opportune market scenario for urodynamic device manufacturers in the European region through 2033. Changing regulatory landscape is also expected to help urodynamic devices market development in this region to a certain extent.

Why Should Urodynamic Device Vendors Invest in the United States?

“High Healthcare Expenditure and Favorable Reimbursement Scenario”

The United States has one of the most popular and advanced healthcare infrastructure in the world, which is expected to be a prime prospect for urodynamic device shipments in the country over the coming years.

Other factors such as favorable reimbursement policies, high incidence of renal disorders, a growing number of product launches, and increasing product approvals from (the Food and Drug Administration of the United States) FDA are also projected to uplift sales of urodynamic devices throughout the forecast period.

  • As per statistics provided by the Centers for Disease Control and Prevention, around 15% of adults in the United States were estimated to have chronic kidney disease in 2021.

The United States is the leading market in the North American region in terms of volume as well as revenue share, and is followed by Canada, which is projected to exhibit attractive growth scope for urodynamic device companies over the coming years.

Category-wise Insights

Which Product Will Witness a Hike in Demand?

“Electromyography Devices to Outshine Other Products”

Based on product type, the market for urodynamic devices is segmented into uroflowmetry, ambulatory urodynamic devices, cystometers, video urodynamic devices, electromyography, urodynamic catheters, urodynamic pumps & transducer sets.

Among all types of urodynamic equipment, electromyography devices are anticipated to account for a substantial market share in the global industry across the forecast period. The growing prevalence of kidney disorders and the high incidence of bladder cancer are expected to be prime factors driving shipments of electromyography equipment over the next ten years.

  • The American Cancer Society estimates about 82,290 new cases of bladder cancer to be recorded in the year 2023 and around 16,710 deaths from the disease for the same year.

Increasing investments in research and development of new medical devices coupled with the approval and launch of new electromyography systems are also expected to contribute to growth in this segment over the coming years.

Competitive Landscape

Leading urodynamic device companies are focusing on enhancing their brand image through innovative marketing and rebranding to stand out from the crowd in the global marketplace.

  • In October 2021, a specialist medtech company called Laborie Medical Technologies Inc. announced that it had refreshed its brand identity, mission, vision, and core values. The company did this to grow its brand on a global level and redefine its stance in the industry.

Key Segments of Urodynamic Devices Industry Research

  • By Product Type :

    • Uroflowmetry
    • Ambulatory Urodynamic Devices
    • Cystometers
    • Video Urodynamic Devices
    • Electromyography
    • Urodynamic Catheters
    • Urodynamic Pumps & Transducer Sets
  • By End User :

    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Urology Clinics
    • Others
  • By Region :

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

- FAQs -

What is the current urodynamic devices market size?

The global urodynamic devices market accounts for a valuation of US$ 299.5 million in 2023.

How big will the market be by the end of 2033?

By 2033-end, worldwide demand for urodynamic devices is projected to reach a value of US$ 581.8 million.

What is the projected market expansion rate for urodynamic devices?

From 2023 to 2033, urodynamic device shipments are forecasted to increase at 6.8% CAGR.

Which is the most lucrative regional market for urodynamic device companies?

Asia Pacific is anticipated to emerge as a highly attractive market for urodynamic device suppliers over the decade.

Who are the prime urodynamic device manufacturers in the industry?

Albyn Medical Ltd., Ambu Inc., Medica SpA, Dantec Dynamics A/S, and Boston Scientific Corporation are key producers of urodynamic devices.

Urodynamic Devices Market

Schedule a Call